Latest News and Press Releases

Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026

Vivos Announces Binding Agreement for Senior Debt-to-Equity Exchange of Up to $4.5 Million from Streeterville Capital to Support Continued Nasdaq Listing

Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update

Vivos Therapeutics Reports Full Year 2025 Financial Results Full Year 2025 revenue increased 16%

Vivos Therapeutics Schedules Release of Full Year 2025 Financial Results and Conference Call

Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners

Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare

Recent Study Confirms Fundamental Correlation Between Severity of Obstructive Sleep Apnea and Oral Anatomy

Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies

Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds